Gemina Laboratories Ltd. (OTCPK: GLAB.F)
Health Care · Biotechnology · CA
$—
— today · — 1Y
Gemina Laboratories Ltd. (OTCPK: GLAB.F) operates in the Biotechnology industry within the Health Care sector.
trading between 0.04 and 0.92.
Tweenvest scores Gemina Laboratories Ltd. across four factors: quality 19/100. Its strongest factor is quality.
GLAB.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $7.76K
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $0.92
- 52-week low
- $0.04
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 6
- Next earnings
- —
About Gemina Laboratories Ltd.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
- ISIN
- CA3686501071
- Founded
- 2017
- Listed since
- Aug 12, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $0.00 | — |
| Calithera Biosciences, Inc.OTCPK: CALA | $5.00 | $0.00 | -99.00% |
| Biocept, Inc.OTCPK: BIOC.Q | $3.00 | $0.00 | -99.50% |
| Yield10 Bioscience, Inc.OTCPK: YTEN.Q | $1.00 | $— | — |
| LadRx CorporationOTCPK: LADX | $0.00 | $0.00 | -99.50% |
Figures last refreshed Oct 18, 2026.